alexa Lung Transplant And Outcomes: A Single-center Experience | 6768
ISSN: 2161-1076

Surgery: Current Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Lung transplant and outcomes: A single-center experience

International Conference and Exhibition on Surgery, Anesthesia & Trichology

Iskander Al-Githmi

ScientificTracks Abstracts: Surgery Curr Res

DOI: 10.4172/2161-1076.S1.005

Introduction: Lung transplant is the preferred treatment for several end-stage pulmonary diseases. More than 20 years have passed since the first successful clinical lung transplant was performed by the Toronto Group in 1983. Objectives: This article discusses our initial experience with single and double lung transplant. Study design: A retrospective analysis was done on 11 consecutive lung transplants for end-stage pulmonary diseases performed at our institution between 2008 and 2010. Materials and Methods: Major indications were idiopathic pulmonary fibrosis (n=6), bronchiectasis (n=2), primary pulmonary hypertension (n=1), lymphangioleiomyomatosis (n=1), and scleroderma (n=1). Results: Two patients (18.2%) died within 30 days of surgery. One- and 2-year survival rates for the recipients were 81.8% and 72.7%. Sepsis caused the deaths of 2 recipients. Conclusions: Although sepsis and chronic rejection limit the benefits, lung transplant gives many patients with end-stage pulmonary disease the ability for a better quality of life.

Al-Githmi received his MD degree from King Abdulaziz University, Saudi Arabia and his FRCSC general surgery, thoracic surgery, Critical Care of Medicine and cardiac surgery from the University of Manitoba, University of Alberta, and University of Toronto all in Canada. From 2001-2005 he was a consultant cardiothoracic surgeon and director of lung transplant program at King Faisal Specialist Hospital and Research Center, Saudi Arabia. From 2005-2007 he was Assistant Professor of Surgery at the Chinese University of Hong Kong, Hong Kong SAR, and currently is Associate Professor of Surgery at King Abdulaziz University, Saudi Arabia. Dr. Al-Githmi has special interest in coronary artery bypass grafting, mitral valve repair, thoracic aneurysm surgery, minimal invasive thoracic surgery and lung transplantation. Dr. Al-Githmi has authored and co-authored of several articles and papers published in leading journals. Al-Githmi is a member of the Royal College of Physicians and Surgeons of Canada, American College of Chest Physicians, American College of Surgeons, Society of Thoracic Surgeons, European Association for Cardiothoracic Surgery, American Heart Association, Canadian Cardiovascular Society, Michael De Bakey international Surgical Society and Saudi Council for Health Specialties.

Leave Your Message 24x7